The Food and Drug Administration officially blessed the practice of providing COVID-19 booster shots to 12- to 15-year-old children, as well as for immunocompromised children between 5 and 11 years of age. In the same announcement, the FDA shortened the recommended interval between initial vaccination and boosters for some patients. Based on “new evidence,” the agency suggests that patients who received two doses of the Pfizer vaccine get a booster shot 5 months after completing their initial immunizations. The recommended intervals for those who received the Johnson & Johnson vaccine or the Moderna vaccine remain at 2 months and 6 months, respectively. These changes present an opportunity to both strengthen your position as an essential community health resource and to provide maximum protection for patients in your community. Ensure you spread the word to those who present for any reason.
Opportunity Knocks as Millions More Americans Become Eligible for COVID-19 Boosters